I have sent it to many of the VIPs...
peace,
tenalouise
____________________________

I'm doing research for a book about a drug called GDNF that was developed by Synergen in the early 1990s and was later bought by Amgen. The drug was used to treat Parkinson's Disease and had performed well in animal testing. Early human tests also showed promise.
In 2003, Amgen conducted a more scientific trial that involved 34 patients in the United States and Canada. Some of these patients reported remarkable improvements after several months on GDNF.

In Sept. 2004, Amgen halted the trial. Amgen officials said not only did they have safety concerns about the drug, but the drug was ineffective -- it had failed to meet the goals Amgen had set when the trial began.

Since then, a group of patients and doctors has fought in the courts, in the media and on Capitol Hill for access to the drug. They say they believe GDNF works and that Amgen should not have halted the trial.

If you have any information about Synergen, Amgen, GDNF or a related topic that could be helpful in writing this book, please send it my way. Also, please send contact info for anyone involved in the trials -- doctors or patients. Your anonymity is guaranteed.

You can reach me at:

GDNFbook@Gmail.com or (361) 774-9400

Thank you,

Nick Nelson
Freelance Journalist
______________________________